Investigation of Upper Extremity Functions in Patients With Rheumatoid Arthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-25

Study Completion Date

2027-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are limited studies in the literature evaluating upper extremity functional exercise capacity, muscle functions and daily living activities in rheumatoid arthritis patients. In this context, the aim of this study was to investigate upper extremity exercise capacity, hand grip strength and daily living activities in rheumatoid arthritis patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Relationship Between Grip Endurance, Disability of Upper Extremity and Quality of Life in Patients With RA

NCT04563455

Rheumatoid Arthritis

COMPLETED

Investigation of Muscle Oxygenation in Patients With Rheumatoid Arthritis

NCT06769386

Rheumatoid Arthritis

RECRUITING

Effects of Task-Oriented Training and Mulligan Mobilization on Hand Function, Pain and Quality of Life in Patients With Rheumatoid Arthritis

NCT07029113

Rheumatic Arthritis

COMPLETED NA

Comparison of the Effects of Aerobic and Resistive Exercises in Female Patients With Rheumatoid Arthritis

NCT04570280

Rheumatoid Arthritis Exercise Exercise Therapy

COMPLETED NA

Effectiveness of Technology-Supported Hand Strengthening and Stretching Exercises in Patients With Rheumatoid Arthritis

NCT04365842

Rheumatoid Arthritis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rheumatoid arthritis is an inflammatory autoimmune chronic and systemic disease of unknown etiology. In addition to musculoskeletal involvement, lung involvement can also be observed in patients. Lung involvement and accompanying symptoms cause deterioration of physical function, quality of life and functional capacity. In rheumatoid arthritis, dyspnea can be observed during exertion due to disease progression, drug toxicity and respiratory/cardiovascular morbidities. In patients, decreased respiratory muscle strength, respiratory functions, carbon monoxide diffusion capacity and oxygen consumption also cause decreased physical functions. It has been reported that upper extremity exercise capacity and functional performance are reduced in patients with interstitial lung disease. It is known that peripheral muscle strength is an independent determinant of exercise capacity in interstitial lung disease. Rheumatoid cachexia, characterized by decreased muscle mass and increased fat mass, is observed in rheumatoid arthritis patients. Since the patients' accessory respiratory muscles are also affected, it can negatively affect their daily life activities, especially those that use the upper extremities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rheumatoid arthritis group

Rheumatoid arthritis patients in clinical remission between the ages of 18-75, who are followed up in the Kirsehir Ahi Evran University Physical Medicine and Rehabilitation Department outpatient clinic, will be included in the study.

No interventions assigned to this group

Control group

As a control group, healthy individuals between the ages of 18-75 years, who are similar to the patients in terms of age and gender, have no diagnosed disease, will be included in the study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with rheumatoid arthritis,
* Between the ages of 18-75 years,
* Patients who volunteer to participate in the study will be included in the study.

* Between the ages of 18-75 years,
* Volunteer to participate in the study will be included in the study.

Exclusion Criteria

* Those with serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions,
* Those who have participated in a planned exercise program in the last three months
* Those with cognitive impairment that will cause difficulty in understanding and following exercise test instructions
* Patients with contraindications for exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study.

* Those with any diagnosed chronic or systemic disease,
* Those who smoke 10 packs x years or more,
* Those who have pneumonia or any acute infection,
* Healthy individuals with any psychiatric disorder will not be included in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes